A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT06468358 · RECRUITING
Trial details
- NCT number
- NCT06468358
- Sponsor
- L & L Bio Co., Ltd., Ningbo, China
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2026-12-30
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.